Latest Asx News

Page 5 of 2814
Clarity Pharmaceuticals has completed final follow-up assessments for every participant in its registrational Phase III AMPLIFY trial of 64Cu-SAR-bisPSMA. Topline results from AMPLIFY and the related CLARIFY trial are expected in the first half of 2027, with the data intended to support US FDA applications.
Victor Sage
Victor Sage
19 Nov 2026
Native Mineral Resources has poured a record 972.7oz of gold doré at Blackjack, with internal assays estimating 463.5oz of refined gold. That would take November production above October’s record, although Perth Mint confirmation is still pending.
Maxwell Dee
Maxwell Dee
19 Nov 2026
Actinogen Medical’s pivotal XanaMIA trial produced a mixed result: Xanamem showed a small, non-significant benefit across the full 247-patient population, but a prespecified older-patient analysis found a statistically significant difference in disease stabilisation. The company will continue its open-label extension, suspend future Phase 3 spending and seek development partners.
Victor Sage
Victor Sage
19 Nov 2026
Aurum Resources has reported thick gold intercepts from 21 diamond holes at its BST1 deposit in Côte d’Ivoire, with mineralisation still open along strike and at depth. The results add exploration momentum as the company prepares a Boundiali ore reserve update and definitive feasibility study targeted for the first quarter of 2027.
Maxwell Dee
Maxwell Dee
19 Nov 2026
Future Metals has identified a new, untested copper target north of Eileen Bore Main, with up to AU$88,250 in Western Australian government co-funding offered for diamond drilling. The target is supported by coincident gravity, electromagnetic and magnetic anomalies, but its geological source remains unconfirmed.
Maxwell Dee
Maxwell Dee
19 Nov 2026
Emeco expects FY27 Operating EBITDA of $275 million to $285 million as mining equipment utilisation improves and new project deployments gather pace. The company is also pointing to FY28 earnings growth aligned with its 20% return on capital target.
Victor Sage
Victor Sage
19 Nov 2026
Chrysos Corporation (ASX:C79) has reported a strong opening four months of FY27, with unaudited revenue up 27% and PhotonAssay sample volumes up 43%. The company reaffirmed its full-year guidance while expanding its deployed fleet and contracted pipeline.
Victor Sage
Victor Sage
19 Nov 2026
Nufarm has delivered a sharp FY26 recovery in underlying earnings and cash generation, with leverage falling to 2.0 times despite a 7% revenue decline. The statutory loss, no ordinary dividend and ongoing restructuring show the turnaround remains unfinished.
Ada Torres
Ada Torres
19 Nov 2026
Catalina Resources has restarted the Badja Gold Project Scoping Study and cleared the way for a 4,365-metre drilling program beginning in January 2027. The parallel work will test extensions of the high-grade Gnows Nest lode while feeding new drilling data into mine design.
Maxwell Dee
Maxwell Dee
19 Nov 2026
Worley has reaffirmed mid to high single-digit growth expectations for FY2027 despite a weaker FY2026, while shareholders delivered a strong protest vote on executive remuneration. The AGM also began the search for a successor to long-serving Chair John Grill.
Victor Sage
Victor Sage
19 Nov 2026
Vulcan Energy has secured a five-year lithium and geothermal exploration licence beside its Lionheart project in Germany, opening a potential expansion pathway near infrastructure already under construction. The company is targeting a maiden Landau-Ost resource estimate in the first quarter of 2027, but development remains subject to further study.
Victor Sage
Victor Sage
19 Nov 2026
Challenger has received a revised $12.20-per-share proposal from TAL Daiichi Life Australia for the 79.5% of shares TAL does not already own. The Challenger board says the non-binding, conditional offer does not represent fair value and shareholders need not act.
Claire Turing
Claire Turing
19 Nov 2026

Browse the archive

Full archive